Caldwell & Orkin’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-103,000
Closed -$1.09M 96
2016
Q4
$1.09M Buy
103,000
+55,000
+115% +$559K 0.69% 54
2016
Q3
$455K Sell
48,000
-302,000
-86% -$2.75M 0.31% 55
2016
Q2
$2.94M Buy
+350,000
New +$2.81M 1.27% 31
2015
Q1
Sell
-131,000
Closed -$1.04M 98
2014
Q4
$1.04M Buy
131,000
+48,000
+58% +$372K 0.58% 54
2014
Q3
$620K Buy
83,000
+41,000
+98% +$292K 0.45% 53
2014
Q2
$284K Buy
+42,000
New +$251K 0.14% 81

Other funds holding LRCX

Caldwell & Orkin's LRCX Position: Q1 2017 in Review

Caldwell & Orkin sold out of Lam Research (LRCX) in Q1 2017, closing a stake of 103,000 shares — an estimated $1.09M sold.

Caldwell & Orkin first reported a position in LRCX in Q2 2014 and held it in 6 quarters. The position peaked at $2.94M in Q2 2016. 669 funds tracked by Wall St. Rank hold LRCX as of Q1 2017.

  • Caldwell & Orkin reported no remaining Lam Research position as of Q1 2017 after selling out during the quarter.
  • Caldwell & Orkin sold 103,000 Lam Research shares in Q1 2017, an estimated $1.09M.
  • Caldwell & Orkin first reported a position in Lam Research in Q2 2014 and held it in 6 quarters.
  • Caldwell & Orkin's Lam Research position peaked at $2.94M in Q2 2016.
  • 669 funds tracked by Wall St. Rank held Lam Research as of Q1 2017.

Based on Caldwell & Orkin's 13F filing for Q1 2017, filed 5 May 2017.